Snake venoms and hemostasis

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 8, 2005, Pages 1791-1799

  Lu, Q ^a   Clemetson, J M ^a   Clemetson, Kenneth J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

C type lectins; Disintegrins; L amino acid oxidases; Metalloproteinases; Phospholipases; Serine proteases

Indexed keywords

AMINO ACID OXIDASE; BLOOD CLOTTING FACTOR; DISINTEGRIN; HYDROGEN PEROXIDE; LECTIN; METALLOPROTEINASE; PHOSPHOLIPASE; SERINE PROTEINASE; SNAKE VENOM; THROMBOXANE A2; VON WILLEBRAND FACTOR;

BLEEDING; BLOOD CLOTTING; CONFERENCE PAPER; ENZYME ACTIVITY; FIBRINOLYSIS; HEMOSTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOCYTE FUNCTION;

AMINO ACID OXIDOREDUCTASES; ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; HYDROGEN PEROXIDE; INTEGRINS; LECTINS; MODELS, BIOLOGICAL; PHOSPHOLIPASES; PROTEIN BINDING; SNAKE VENOMS; THROMBOXANE A2;

EID: 28344452906     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01358.x     Document Type: Conference Paper

References (100)

1. Meier J. Stocker K. Effects of snake venoms on hemostasis. Crit Rev Toxicol 1991; 21: 171-82.
2. Ouyang C, Teng CM, Huang TF. Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 1992; 30: 945-66.
3. Marsh NA. Snake venoms affecting the haemostatic mechanism - a consideration of their mechanisms, practical applications and biological significance. Blood Coagul Fibrinolysis 1994; 5: 399-410.
4. Markland FS. Snake venoms and the hemostatic system. Toxicon 1998; 36: 1749-800.
5. Braud S, Bon C. Wisner A. Snake venom proteins acting on hemostasis. Biochimie 2000; 82: 851-9.
6. Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood 2001; 101: 20-30.
7. Rosing J. Govers-Riemslag JW, Yukelson L, Tans G. Factor V activation and inactivation by venom proteases. Haemostasis 2001; 31: 241-6.
8. Kalafatis M, Beck DO, Mann KG. Structural requirements for expression of factor Va activity. J Biol Chem 2003; 278: 33550-61.
9. Tokunaga F, Nagasawa K, Tamura S, Miyata T, Iwanaga S, Kisiel W. The factor V-activating enzyme (RVV-V) from Russell's viper venom. Identification of isoproteins RVV-Vα, -Vβ, and -Vγ and their complete amino acid sequences. J Biol Chem 1988; 263: 17471-81.
10. Tans G, Rosing J. Snake venom activators of factor X: an overview. Haemostasis 2001; 31: 225-33.
11. Takeya H, Nishida S, Miyata T. Kawada S, Saisaka Y, Morita T, Iwanaga S. Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J Biol Chem 1992; 267: 14109-17.
12. Lindquist PA, Fujikawa K. Davie EW. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom. J Biol Chem 1978; 253: 1902-9.
13. Rosing J, Tans G. Structural and functional properties of snake venom prothrombin activators. Toxicon 1992; 30: 1515-27.
14. Rao VS, Joseph JS, Kini RM. Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa. Biochem J 2003; 369: 635-42.
15. Venkateswarlu D, Krishnaswamy S, Darden TA, Pedersen LG. Three-dimensional solution structure of Tropidechis carinatus venom extract trocarin: a structural homologue of Xa and prothrombin activator. J Mol Model (Online) 2002; 8: 302-13.
16. Rao VS, Swarup S, Manjunatha Kini R. The catalytic subunit of pseutarin C, a group C prothrombin activator from the venom of Pseudonaju texiilis is structurally similar to mammalian blood coagulation factor Xa. Thromb Haemost 2004; 92: 509-21.
17. Pirkle H. Thrombin-like enzymes from snake venoms: an updated inventory. Scientific and Standardization Committee's Registry of Exogenous Hemostatic Factors. Thromb Haemost 1998; 79: 675-83.
18. Castro HC, Zingali RB. Albuquerque MG, Pujol-Luz M, Rodrigues CR. Snake venom thrombin-like enzymes: from reptilase to now. Cell Mol Life Sci 2004; 61: 843-56.
19. Morita T. Use of snake venom inhibitors in studies of the function and tertiary structure of coagulation factors. Int J Hematol 2004; 79: 123-9.
20. Mizuno H, Fujimoto Z. Koizumi M, Kano H, Atoda H, Morita T. Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: implication of central loop swapping based on deletion in the linker region. J Mol Biol 1999; 289: 103-12.
21. Mizuno H, Fujimoto Z, Atoda H, Monta T. Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Proc Natl Acad Sci USA 2001; 98: 7230-4.
22. 2+-bound Gla domain of factor IX complexed with binding protein. J Biol Chem 2003; 278: 24090-4.
23. Gempeler-Messina PM, Volz K, Buhler B, Muller C. Protein C activators from snake venoms and their diagnostic use. Haemostasis 2001; 31: 266-72.
24. Zingali RB, Jandrot-Perrus M, Guillin MC, Bon C. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. Biochemistry 1993; 32: 10794-802.
25. Arocas V, Zingali RB, Guillin MC, Bon C, Jandrot-Perrus M. Bothrojaracin: a potent two-site-directed thrombin inhibitor. Biochemistry 1996; 35: 9083-9.
26. Zingali RB, Bianconi ML, Monteiro RQ. Interaction of bothrojaracin with prothrombin. Haemostasis 2001; 31: 273-8.
27. Castro HC, Fernandes M, Zingali RB. Identification of bothrojaracin-like proteins in snake venoms from Bothrops species and Lachesis muta. Toxicon 1999; 37: 1403-16.
28. 2 - a structural review. Toxicon 1996; 34: 827-41.
29. 2 enzymes. Toxicon 2003; 42: 827-40.
30. 2 by sequence analysis and site directed mutagenesis. Toxicon 2003; 42: 869-83.
31. Markland FS Jr. Inventory of α- and β-fibrinogenases from snake venoms. For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1991; 65: 438-43.
32. Matsui T, Fujimura Y, Titani K. Snake venom proteases affecting hemostasis and thrombosis. Biochim Biophys Acta 2000; 1477: 146-56.
33. Jia EG, Shimokawa K, Bjarnason JB, Fox JW. Snake venom metalloproteinases: structure, function and relationship to the ADAMs family of proteins. Toxicon 1996; 34: 1269-76.
34. Zhang Y, Wisner A, Xiong Y, Bon C. A novel plasminogen activator from snake venom. Purification, characterization, and molecular cloning. J Biol Chem 1995; 270: 10246-55.
35. Park D, Kim H, Chung K, Kim DS, Yun Y. Expression and characterization of a novel plasminogen activator from Agkistrodon halys venom. Toxicon 1998; 36: 1807-19.
36. Sanchez EF, Santos CI, Magalhaes A, Diniz CR, Figueiredo S, Gilroy J, Richardson M. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom. Arch Biochem Biophys 2000; 378: 131-41.
37. Parry MA, Jacob U, Huber R, Wisner A, Bon C, Bode W. The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases. Structure 1998; 6: 1195-206.
38. Zhang Y, Wisner A, Maroun RC, Choumet V, Xiong Y, Bon C. Trimeresurus stejnegeri snake venom plasminogen activator. Site-directed mutagenesis and molecular modeling. J Biol Chem 1997; 272: 20531-7.
39. Braud S, Le Bonniec BF, Bon C, Wisner A. The stratagem utilized by the plasminogen activator from the snake Trimeresurus stejnegeri to escape serpins. Biochemistry 2002; 41: 8478-84.
40. Hati R, Mitra P, Sarker S, Bhattacharyya KK. Snake venom hemorrhagins. Crit Rev Toxicol 1999; 29: 1-19.
41. Hite EA, Jia EG, Bjarnason JB, Fox JW. cDNA sequences for four snake venom metalloproteinases: structure, classification, and their relationship to mammalian reproductive proteins. Arch Biochem Biophys 1994; 308: 182-91.
42. Grams F, Huber R, Kress LF, Moroder L, Bode W. Activation of snake venom metalloproteinases by a cysteine switch-like mechanism. FEBS Lett 1993; 335: 76-80.
43. Gutierrez JM, Rucavado A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie 2000; 82: 841-50.
44. Schlondorff J, Blobel CP. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J Cell Sci 1999; 112: 3603-17.
45. McLane MA, Marcinkiewicz C, Vijay-Kumar S, Wierzbicka-Patynowski I, Niewiarowski S. Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med 1998; 219: 109-19.
46. 3 blockade of endothelial cells. Mol Pharmacol 2001; 59: 1333-42.
47. 1 integrin in vitro and angiogenesis in vivo. Cancer Res 2003; 63: 2020-3.
48. Golubkov V, Hawes D, Markland FS. Anti-angiogenic activity of contortrostatin, a disintegrin from Agkistrodon contortrix contortrix snake venom. Angiogenesis 2003; 6: 213-24.
49. Cominetti MR, Terruggi CH, Ramos OH, Fox JW, Mariano-Oliveira A, De Freitas MS, Figueiredo CC, Morandi V, Selistre-de-Araujo HS. Alternagin-C, a disintegrin-like protein, induces vascular endothelial cell growth factor (VEGF) expression and endothelial cell proliferation in vitro. J Biol Chem 2004; 279: 18247-55.
50. Stromblad S, Cheresh DA. Integrins, angiogenesis and vascular cell survival. Chem Biol 1996; 3: 881-5.
51. Cheresh DA. Death to a blood vessel, death to a tumor. Nat Med 1998; 4: 395-6.
52. Yeh CH, Wang WC, Hsieh TT, Huang TF. Agkistin, a snake venom-derived glycoprotein Ib antagonist, disrupts von Willebrand factor-endothelial cell interaction and inhibits angiogenesis. J Biol Chem 2000; 275: 18615-8.
53. 1 agonist, induces angiogenesis via expression of vascular endothelial growth factor. Blood 2004; 103: 2105-13.
54. Clemetson KJ, Navdaev A, Dormann D, Du XY, Clemetson JM. Multifunctional snake C-type lectins affecting platelets. Haemostasia 2001; 31: 148-154.
55. Andrews RK, Gardiner EE, Berndt MC. Snake venom toxins affecting platelet function. Methods Mol Biol 2004; 273: 335-48.
56. Fukuda K, Doggett TA, Bankston LA, Cruz MA, Diacovo TG, Liddington RC. Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure (Camb) 2002; 10: 943-50.
57. Maita N, Nishio K, Nishimoto E, Matsui T, Shikamoto Y, Morita T, Sadler JE, Mizuno H. Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibα binding mechanism induced by snake venom proteins. J Biol Chem 2003; 278: 37777-81.
58. Lu Q, Navdaev A, Clemetson JM, Clemetson KJ. GPIb is involved in platelet aggregation induced by mucetin, a snake C-type lectin protein from Chinese habu (Trimeresurus mucrosquamatus) venom. Thromb Haemost 2004; 91: 1168-76.
59. Navdaev A, Dormann D, Clemetson JM, Clemetson KJ. Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMkappa responsible for platelet agglutination in plasma and inducing signal transduction. Blood 2001; 97: 2333-41.
60. Polgar J, Clemetson JM, Kehrel BE, Wiedemann M, Magnenat EM, Wells TN, Clemetson KJ. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem 1997; 272: 13576-83.
61. Lee WH, Du XY, Lu QM, Clemetson KJ, Zhang Y. Stejnulxin, a novel snake C-type lectin-like protein from Trimeresurus stejnegeri venom is a potent platelet agonist acting specifically via GPVI. Thromb Haemost 2003; 90: 662-71.
62. Du XY, Clemetson JM, Navdaev A, Magnenat EM, Wells TN, Clemetson KJ. Ophioluxin, a convulxin-like C-type lectin from Ophiophagus hannah (King cobra) is a powerful platelet activator via glycoprotein VI. J Biol Chcm 2002; 277: 35124-32.
63. Dormann D, Clemetson JM, Navdaev A, Kehrel BE, Clemetson KJ. Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib. Blood 2001; 97: 929-36.
64. Du X-Y, Magnenat E, Wells TN, Clemetson KJ. Alboluxin, a snake C-type lectin from Trimeresurus albolahris venom is a potent platelet agonist acting via GPIb and GPVI. Thromh Haemost 2002; 87: 692-8.
65. Kanaji S, Kanaji T, Furihata K, Kato K, Ware JL, Kunicki TJ. Convulxin binds to native, human glycoprotein Ibα. J Biol Chem 2003; 278: 39452-60.
66. 2-I domain. Mol Biol 2004; 341: 519-27.
67. 1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J Biol Chem 2001; 276: 12274-84.
68. 1 integrin and glycoprotein Ib, activating Syk and phospholipase Cγ2, but does not involve the glycoprotein VI/Fc receptor γ chain collagen receptor. J Biol Chem 2001; 276: 20882-9.
69. 1. Thromb Haemost 2001; 86: 1277-83.
70. 1 integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibα. J Biol Chem 2001; 276: 25121-6.
71. Fujii Y, Okuda D, Fujimoto Z, Horii K, Morita T, Mizuno H. Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. J Mol Biol 2003; 332: 1115-22.
72. 1's open conformation and promotes its oligomerization. J Mol Biol 2004; 342: 1625-36.
73. Bilgrami S, Tomar S, Yadav S, Kaur P, Kumar J, Jabeen T, Sharma S, Singh TP. Crystal structure of schistatin. a disintegrin homodimer from saw-scaled viper (Echis carinutus] at 2.5 Å resolution. J Mol Biol 2004; 341: 829-37.
74. Marrakchi N, Barbouche R, Guermazi S, Bon C, el Ayeb M. Procoagulant and platelet-aggregating properties of cerastocytin from Cerastes cerastes venom. Toxicon 1997; 35: 261-72.
75. Santos BF, Serrano SM, Kuliopulos A, Niewiarowski S. Interaction of viper venom serine peptidases with thrombin receptors on human platelets. FEBS Lett 2000; 477: 199-202.
76. Jia LG, Wang XM, Shannon JD, Bjarnason JB, Fox JW. Function of disintegrin-like/cysteine-rich domains of atrolysin A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists. J Biol Chcm 1997; 272: 13094-102.
77. Shimokawa K, Shannon JD, Jia LG, Fox JW. Sequence and biological activity of catrocollastatin-C: a disintegrin-like/cysteine-rich two-domain protein from Crotalus atrox venom. Arch Biochem Biophys 1997; 343: 35-43.
78. 1- integrin by the snake venom metalloproteinase jararhagin. Biochem J 1996; 320: 635-41.
79. Zhou Q, Dangelmaier C, Smith JB. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem Biophys Res Commun 1996; 219: 720-6.
80. Liu CZ, Huang TF. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Arch Biochem Biophys 1997; 337: 291-9.
81. Hamako J, Matsui T, Nishida S, Nomura S, Fujimura Y, Ito M, Ozeki Y, Titani K. Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naha kaoulhia cobra venom. Thromh Haemost 1998; 80: 499-505.
82. Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα. Identification of the sulfated tyrosine/ anionic sequence Tyr276-Glu282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry 1996; 35: 4929-38.
83. Tseng YL, Lee CJ, Huang TF. Effects of a snake venom metalloproteinase, triflamp, on platelet aggregation, platelet-neutrophil and neutrophil-neutrophil interactions: involvement of platelet GPIbα and neutrophil PSGL-1. Thromb Haemost 2004; 91: 315-24.
84. Wu WB, Peng HC, Huang TF. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox. Thromb Haemost 2001; 86: 1501-11.
85. Andrews RK, Gardiner EE, Asazuma N, Berlanga O, Tulasne D, Nieswandt B, Smith AI, Berndt MC, Watson SP. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI. J Biol Chem 2001; 276: 28092-7.
86. 2: protein- versus phospholipid-dependent mechanism of action. Haemostasis 2001; 31: 279-87.
87. Kini RM, Evans HJ. Effects of snake venom proteins on blood platelets. Toxicon 1990; 28: 1387-422.
88. Teng CM, Chen YH, Ouyang C. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russelli snake venom. Biochim Biophys Acta 1984; 772: 393-402.
89. 2 from Ophiophagus hannah snake venom. Life Sci 1997; 61: 2211-7.
90. 2 from the venom of the Papuan black snake (Pseudechis papuanus). Biochim Biophys Acta 1995; 1250: 137-43.
91. Tan NH, Ponnudurai G. Comparative study of the enzymatic, hemorrhagic, procoagulant and anticoagulant activities of some animal venoms. Comp Biochem Physiol C 1992; 103: 299-302.
92. Ouyang C, Huang TF. Inhibition of platelet aggregation by 5′-nucle-otidase purified from Trimeresurus gramineus snake venom. Toxicon 1983;21:491-501.
93. Du XY, Clemetson KJ. Snake venom L-amino acid oxidases. Toxicon 2002; 40: 659-65.
94. Pawelek PD, Cheah J, Coulombe R, Macheroux P, Ghisla S, Vrielink A. The structure of L-amino acid oxidase reveals the substrate trajectory into an enantiomerically conserved active site. EMBO J 2000; 19: 4204-15.
95. Nathan I, Dvilansky A, Yirmiyahu T, Aharon M, Livne A. Impairment of platelet aggregation by Echis colorata venom mediated by L-amino acid oxidase or H2O2. Thromb Haemost 1982; 48: 277-82.
96. Takatsuka H, Sakurai Y, Yoshioka A, Kokubo T, Usami Y, Suzuki M, Matsui T, Titani K, Yagi H, Matsumoto M, Fujimura Y. Molecular characterization of L-amino acid oxidase from Agkistrodon halys blomhoffii with special reference to platelet aggregation. Biochim Biophys Acta 2001; 1544: 267-77.
97. Sakurai Y, Takatsuka H, Yoshioka A, Matsui T, Suzuki M, Titani K, Fujimura Y. Inhibition of human platelet aggregation by L-amino acid oxidase purified from Naja naja kaouthia venom. Toxicon 2001; 39: 1827-33.
98. Stabeli RG, Marcussi S, Carlos GB, Pietro RC, Selistre-de-Araujo HS, Giglio JR, Oliveira EB, Scares AM. Platelet aggregation and antibacterial effects of an L-amino acid oxidase purified from Bothrops alternatus snake venom. Bioorg Med Chem 2004; 12: 2881-6.
99. Lu QM, Wei Q, Jin Y, Wei JF, Wang WY, Xiong YL. L-Amino acid oxidase from Trimeresurus jerdonii snake venom: purification characterization, platelet aggregation-inducing and anti-bacterial effects. J Nat Toxins 2002; 11: 345-52.
100. Zhang H, Teng M, Niu L, Wang Y, Wang Y, Liu Q, Huang Q, Hao Q, Dong Y, Liu P. Purification, partial characterization, crystallization and structural determination of AHP-LAAO. a novel L-amino-acid oxidase with cell apoptosis-inducing activity from Agkistrodon halys pallas venom. Acta Crystallogr D Biol Crystallogr 2004; 60: 974-7.